Mitsui Chemicals has unveiled a new product—InnoCell, a cell culture microplate with high-performance characteristics, designed with outstanding oxygen permeability, that represents a groundbreaking advancement in scientific research tools...
By introducing the Virtual Simulation-based Pharmaceutical Manufacturing Training Program, which is exclusive for pharmacy students, the Karnataka State Pharmacy Council (KSPC) has made a major advancement in pharmacy education
Alembic Pharmaceuticals has entered into a definitive agreement to acquire UK-based Utility Therapeutics Ltd. for USD 12 million, a strategic expansion into the branded anti-infective space in the United States...
Lyfius Pharma Private Limited, a fully owned step-down subsidiary of Aurobindo Pharma, has announced the resumption of production at its Penicillin-G manufacturing facility in Kakinada, Andhra Pradesh
Jiangsu Recbio Technology Company Limited (02179.HK) signed a licensing cooperation agreement with Biological E. Limited (BE), the Indian vaccine and pharmaceuticals industry leader
Biocon Ltd is seeking regulatory approval for its generic version of Ozempic (semaglutide) to get into Canada's high growth obesity drug market, aiming for a submission date of September 2025. This would allow for a...
In a strategic shift to develop its position in India’s growing self-care and over-the-counter (OTC) market, Lupin Limited has formally separated its consumer healthcare division and formed a wholly owned subsidiary called LupinLife Consumer...
With nearly $2 billion in yearly revenues, which is already a record for India's fragmented drug-retailing industry, Apollo Hospitals Enterprises (AHEL), the largest listed healthcare chain in the nation, and its subsidiary Apollo HealthCo
Torrent Pharmaceuticals has become the fifth largest pharmaceuticals company in India by domestic market share when it purchased a controlling stake in JB Chemicals & Pharmaceuticals. This deal is one of the largest mergers in India's...
Biocon Biologics reported that Biocon Sdn. Bhd., its Malaysian subsidiary, has exceeded the milestone of providing the Malaysian Ministry of Health (MoH) with 100 million recombinant human insulin (rh-insulin) cartridges.